Kelly Griffiths Archives | Page 7 of 7

[widget id="surstudio-translator-revolution-3"]

About us
Locations
- Adelaide
  - Level 1
  - 333 King William Street
  - Adelaide SA 5000
  - GPO Box 949, Adelaide SA 5001
  - +61 8 8456 2433
  - +61 8 8456 2499
  - info.sa@gadens.com
  Location Map
- Brisbane
  - Level 11, ONE ONE ONE
  - 111 Eagle Street
  - Brisbane QLD 4000
  - GPO Box 129, Brisbane QLD 4001
  - +61 7 3231 1666
  - +61 7 3229 5850
  - info.qld@gadens.com
  Location Map
- Canberra
  - Level 1
  - 55 Wentworth Avenue
  - Kingston ACT 2604
  - GPO Box 2705, Canberra City ACT 2601
  - +61 2 6163 5050
  - +61 2 6163 5051
  - info.act@gadens.com
  Location map
- Melbourne
  - Level 13, Collins Arch
  - 447 Collins Street
  - Melbourne VIC 3000
  - GPO Box 48, Melbourne VIC 3000
  - +61 3 9252 2555
  - +61 3 9252 2500
  - info.vic@gadens.com
  Location Map
- Perth
  - Lavan (Associate office)
  - Level 20
  - 1 William Street
  - Perth WA 6000
  - PO Box F338, Perth WA 6000
  - +61 8 9288 6000
  - +61 8 9288 6001
  - info.wa@gadens.com
  Location Map
- Sydney
  - Level 29
  - 8 Chifley Square
  - Sydney NSW 2000
  - PO Box H332, Australia Square NSW 1215
  - +61 2 9231 4996
  - +61 2 9163 3000
  - info.nsw@gadens.com
  Location Map
International
Careers
News
Contact us

Immunity for serious financial misconduct – ASIC’s new policy

Overview ASIC has just announced a new policy that allows individuals who think they might have been involved in market manipulation, insider trading, dishonest conduct or other contraventions of Part 7.10 of the Corporations Act 2001 (the Act) to apply for immunity from civil penalty or criminal proceedings. This policy expands ASIC’s ability to identify […]

COVID-19 | TGA issues guidance for advertising of COVID-19 vaccines to Australian public

The roll out of the COVID-19 vaccine in Australia this week brings both excitement and questions about how healthcare services may advertise or promote the vaccines to the general public. The Therapeutic Goods Administration (TGA) has issued guidance to enable vaccine providers, and the broader healthcare sector, to confidently navigate a highly regulated environment, whilst balancing […]